Oligonucleotide affinity ligands developer Aptamer Group has developed a panel of binders to a novel Alzheimer’s disease biomarker, patented by partners at Neuro-Bio, following the demonstration of performance in specifically binding to the target biomarker and functionality in a nasal mucous matrix. Click to read more.
چگونه خلاقیت خود را تقویت کنیم؟ برای خود محدودیت ایجاد کنید bbc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bbc.com Daily Mail and Mail on Sunday newspapers.